Why subscribe?
This newsletter will provide you with information you won’t likely hear on the MSM and the “experts” they have on as guests. When I provide a forecast you should have a fair degree of confidence it will give you an idea of what is going to happen in the next few months. MAPS has accurately prognosed oncoming waves by months in advance every time so far. I currently do this for all of our brothers and sisters out there and do not get a single penny for my efforts, including providing forecast guidance for local public health officials. My pay is a peace of mind knowing you are informed and hopefully impact some lives in a positive manner. No paid subcription is required, by subscribing will get full access to the newsletter, website, full forecast details, and your own local Covid Forecast.
Multiple Algorithm Pathogen Software (MAPS)
The Multiple Algorithm Pathogen Software (MAPS) is a model I have developed over the last 5 years. It can be used to research and forecast SARS-CoV-2 (all variants), influenza, measles, and H5N1, with an easy interface to add more pathogens. It is a modern FORTRAN based code that employs the Message Passing Interface (MPI) to allow simulations on an unlimited number of processors in parallel. It is currently used to resolve North America on ~0.5 square mile pixels to give you a forecasts on multiple scales, from national to local neighborhoods. It is my belief that each locality has a different “COVID” climate established by many factors like mask/vaccination mitigation, meteorology, to local scale interactions. The code can be executed on Windows and Linux based platforms and is freely available up request.
Stay up-to-date
You won’t have to worry about missing anything. Every new edition of the newsletter goes directly to your inbox.
Join the crew
Be part of a community of people who share your interests and want to do your best to help fight the pandemic and other health related issues like RSV and influenza.
To find out more about the company that provides the tech for this newsletter, visit Substack.com.
